Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CCM2L Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA552561
Description
Immunogen sequence: IRRLVFPKAG RRAACRSSVS RRPLHSMPLY PPDYLIDPQI LLCDYLEKEV KFLGHLTWVT SSLNPSSRDE LLQLLDTARQ LKELPLKTTA EQDSILSLSA RCLLLTWRDN EELILRIPTH E Highest antigen sequence identity to the following orthologs: Mouse - 96%, Rat - 94%.
CCM2L gene ontology annotations related to this gene include cardiac atrium morphogenesis; cardiac muscle tissue growth; negative regulation of homotypic cell-cell adhesion; negative regulation of protein binding; positive regulation of fibroblast growth factor production; ventricular trabecula myocardium morphogenesis; wound healing.
Specifications
CCM2L | |
Polyclonal | |
Unconjugated | |
CCM2l | |
C20orf160; C24H20orf160; CCM2 like scaffold protein; CCM2 like scaffolding protein; CCM2l; CCM2-like; ccml2; cerebral cavernous malformation 2; cerebral cavernous malformation 2-like; cerebral cavernous malformations 2 protein-like; dJ310O13.5; LOW QUALITY PROTEIN: cerebral cavernous malformations 2 protein-like; RGD1305202; si:dkey-223d9.2; uncharacterized protein C20orf160 homolog; cerebral cavernous malformations 2 protein-like | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
140706 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.05 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9NUG4 | |
CCM2l | |
Recombinant protein corresponding to Human CCM2L. Recombinant protein control fragment (Product #RP-89709). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction